Oncology & Cancer

Low risk prostate cancer not always low risk

More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ...

Oncology & Cancer

Sugar helps scientists find and assess prostate tumors

A natural form of sugar could offer a new, noninvasive way to precisely image tumors and potentially see whether cancer medication is effective, by means of a new imaging technology developed at UC San Francisco in collaboration ...

Genetics

Scientists find new gene markers for cancer risk

A huge international effort involving more than 100 institutions and genetic tests on 200,000 people has uncovered dozens of signposts in DNA that can help reveal further a person's risk for breast, ovarian or prostate cancer, ...

Oncology & Cancer

Benefits of prostate-specific antigen testing remain unclear

(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, according to a provisional ...

Oncology & Cancer

Integration of MRI screening beneficial for prostate cancer

Integrating magnetic resonance imaging (MRI) into prostate cancer (PCa) screening is associated with a reduction in unnecessary biopsies and overdiagnosis of insignificant disease, according to a review published online April ...

page 2 from 21